4 výsledky
The contents of any patents, patent applications, and references cited throughout this specification are hereby incorporated by reference in their entireties.
TECHNICAL FIELD
The present invention concerns an antibody specific for human ALK (Anaplastic Lymphoma Kinase), in particular a scFv, a
TECHNICAL FIELD
The present invention concerns an antibody specific for human ALK (Anaplastic Lymphoma Kinase), in particular a scFv, a nucleic acid sequence encoding it, its production and its use as a pharmaceutical or for diagnostic purposes. Said antibody is suitable for the local treatment of
TECHNICAL FIELD
The present invention concerns an antibody specific for human ALK (Anaplastic Lymphoma Kinase), in particular a scFv, a nucleic acid sequence encoding it, its production and its use as a pharmaceutical or for diagnostic purposes. Said antibody is suitable for the local treatment of
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention in the field of molecular biology and medicine relates to interfering RNA (RNAi) compositions and methods of using them to reduce the expression of the Met oncogene, a receptor for hepatocyte growth factor/scatter factor